EP Patent

EP1265874A2 — Verfahren zur einfachen herstellung von (3-chlor-4-fluor-phenyl)- 7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin bzw. (3-chlor-4-fluor-phenyl)- 7-(3-morpholin-4-yl-propoxy)-6-amino -quinazolin-4-yl]-amin

Assigned to Goedecke GmbH · Expires 2002-12-18 · 23y expired

What this patent protects

Die Erfindung betrifft eine Eintopf-Reaktion zur Herstellung von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin (I) beziehungsweise von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazolin-4-yl]-amin (VII).

USPTO Abstract

Die Erfindung betrifft eine Eintopf-Reaktion zur Herstellung von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amin (I) beziehungsweise von (3-Chlor-4-fluor-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazolin-4-yl]-amin (VII).

Drugs covered by this patent

Patent Metadata

Patent number: EP1265874A2
Jurisdiction: EP
Classification: —
Expires: 2002-12-18
Drug substance claim: No
Drug product claim: No
Assignee: Goedecke GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.